For medical device manufacturers, gaining access to multiple major markets is usually an important factor in the economic success of new and advanced medical technologies. At the same time, the checkered global landscape for the regulatory approval of new devices typically requires manufacturers to demonstrate compliance with different and often seemingly conflicting regulations and requirements. These differences and discrepancies typically result in a long and costly path to global regulatory approval.
我们的专家将详细解读2023年韩国食品药品安全部(MFDS)指导文件草案更新下韩国医疗器械注册监管要求、分类标准、韩国良好生产规范(KGMP)等相关要求,并将依据多年韩国本地注册经验提供注册案例分享。此外,您还将了解到制造商在面对MFDS监管时需要关注的核心要点,相关研讨会内容包括:
阅读更多新欧盟医疗器械法规2017/745(MDR)新增了对公告机构开展临床评估审查的新要求。该审查新要求的提出将对部分在从医疗器械法令MDD到新医疗器械法规MDR过渡中的医疗器械企业带来面临不符合项的风险。 对此,此场研讨会将特此分享在新欧盟医疗器械法规MDR下,医疗器械如何满足临床评
阅读更多